Latest Prodrugs Stories
JERUSALEM, July 8, 2011 /PRNewswire/ -- IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today announced an update to some of the marketing activities in Russia. Mr Shoham stated, "We are working in Russia with more than one local company. Russia is huge in territory and in population. It is in the corridor for the Afghanistan heroin (the largest supplier of heroin in the world) to western Europe. About 20% of the Afghanistan heroin to Europe is being used in Russia. Every year about...
THOUSAND OAKS, Calif., June 24, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Vectibix® (panitumumab) be approved for use in the European Union (EU) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy (excluding...
Witte Museum, San Antonio--11 a.m. THURS. JUNE 23: 3801 Broadway, San Antonio, TX 78209 Media Invited to News Conference, Q&A with leaders, and follow-on lunch with attendees Will Discuss Huge Official Treatment Gap Numbers Not Widely Known, Exploding Prescription Drug Abuse, New FDA-Approved Science-based Treatment and Breakthroughs, Treatment Impact on Reducing Crime and Improving Lives, and New Tricare Help to Military Service Members Returning from Wars Abroad SAN ANTONIO, June 16,...
RTOG reports on the largest trial to-date for patients with newly diagnosed glioblastoma demonstrating the importance and feasibility of prospective molecular analysis of tumor tissue although finding that patients received no additional benefit from dose-intensive temozolomide as compared to standard adjuvant temozolomide after combined temozolomide and radiotherapy. The integration of tumor analysis with the clinical trial and international collaboration, major components of this...
Treatment was beneficial despite resistance to all standard therapeutic approachesA new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed, say research physicians at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center.The research team found that combining a PARP inhibitor with chemotherapy (temozolomide) offers significant benefit in patients who...
SAN DIEGO, May 11, 2011 /PRNewswire/ -- Accumetrics, Inc., marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a national distribution agreement with Cardinal Health, Inc. to distribute the VerifyNow System to hospitals, health systems and independent laboratories throughout the United States. The VerifyNow System is widely used by...
HINSDALE, Ill., May 9, 2011 /PRNewswire-USNewswire/ -- The Robert Crown Center for Health Education (RCC), in partnership with the Reed Hruby Foundation and the Illinois Consortium on Drug Policy, is developing one of the nation's first heroin education and prevention projects. The goal of the program is to stop the growing trend of heroin use and death. The Reed Hruby Heroin Prevention Project is made possible by a $340,000 gift from the Hruby family of Burr Ridge. This donation was made...
The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN)."Obese patients with kidney disease progress more quickly towards renal failure compared to non-obese patients, and ramipril virtually abolishes this excess risk," comments Carmine Zoccali, MD (CNR-IBIM and...
The US Food and Drug Administration (FDA) is requiring drugmakers to provide educational material to help train physicians on the correct use of drugs as part of the government's new plan to fight prescription drug abuse in the United States. Prescription drug overdose is the fastest-growing drug problem in the country. It is higher than the number of overdoses from the crack cocaine epidemic of the 80s and the black tar heroin epidemic of the 70s combined, the Obama administration says. The...
THOUSAND OAKS, Calif., March 30, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in March by the Committee For Medicinal Products for Human Use (CHMP) for the use of Vectibix in combination with chemotherapy for patients with wild-type KRAS metastatic colorectal cancer (mCRC). Amgen believes that Vectibix in combination with chemotherapy provides an important...
